Annual Retained Earnings
-$381.43 M
-$152.99 M-66.97%
31 December 2023
Summary:
Keros Therapeutics annual retained earnings is currently -$381.43 million, with the most recent change of -$152.99 million (-66.97%) on 31 December 2023. During the last 3 years, it has fallen by -$316.42 million (-486.71%). KROS annual retained earnings is now -5115.01% below its all-time high of -$7.31 million, reached on 31 December 2018.KROS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$522.75 M
-$52.96 M-11.27%
30 September 2024
Summary:
Keros Therapeutics quarterly retained earnings is currently -$522.75 million, with the most recent change of -$52.96 million (-11.27%) on 30 September 2024. Over the past year, it has dropped by -$181.57 million (-53.22%). KROS quarterly retained earnings is now -2560.32% below its all-time high of -$19.65 million, reached on 31 December 2019.KROS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KROS Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -67.0% | -53.2% |
| 3 y3 years | -486.7% | -347.5% |
| 5 y5 years | -5115.0% | - |
KROS Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -486.7% | at low | -347.5% | at low |
| 5 y | 5 years | -5115.0% | at low | -2560.3% | at low |
| alltime | all time | -5115.0% | at low | -2560.3% | at low |
Keros Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$522.75 M(+11.3%) |
| June 2024 | - | -$469.80 M(+10.7%) |
| Mar 2024 | - | -$424.54 M(+11.3%) |
| Dec 2023 | -$381.43 M(+67.0%) | -$381.43 M(+11.8%) |
| Sept 2023 | - | -$341.18 M(+13.1%) |
| June 2023 | - | -$301.74 M(+14.2%) |
| Mar 2023 | - | -$264.24 M(+15.7%) |
| Dec 2022 | -$228.43 M | -$228.43 M(+15.0%) |
| Sept 2022 | - | -$198.72 M(+13.4%) |
| June 2022 | - | -$175.21 M(+18.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -$147.94 M(+19.5%) |
| Dec 2021 | -$123.75 M(+90.4%) | -$123.75 M(+5.9%) |
| Sept 2021 | - | -$116.81 M(+21.0%) |
| June 2021 | - | -$96.52 M(+19.3%) |
| Mar 2021 | - | -$80.90 M(+24.4%) |
| Dec 2020 | -$65.01 M(+230.8%) | -$65.01 M(+19.6%) |
| Sept 2020 | - | -$54.34 M(+28.5%) |
| June 2020 | - | -$42.30 M(+34.1%) |
| Mar 2020 | - | -$31.54 M(+60.5%) |
| Dec 2019 | -$19.65 M(+168.7%) | -$19.65 M |
| Dec 2018 | -$7.31 M | - |
FAQ
- What is Keros Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Keros Therapeutics?
- What is Keros Therapeutics annual retained earnings year-on-year change?
- What is Keros Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Keros Therapeutics?
- What is Keros Therapeutics quarterly retained earnings year-on-year change?
What is Keros Therapeutics annual retained earnings?
The current annual retained earnings of KROS is -$381.43 M
What is the all time high annual retained earnings for Keros Therapeutics?
Keros Therapeutics all-time high annual retained earnings is -$7.31 M
What is Keros Therapeutics annual retained earnings year-on-year change?
Over the past year, KROS annual retained earnings has changed by -$152.99 M (-66.97%)
What is Keros Therapeutics quarterly retained earnings?
The current quarterly retained earnings of KROS is -$522.75 M
What is the all time high quarterly retained earnings for Keros Therapeutics?
Keros Therapeutics all-time high quarterly retained earnings is -$19.65 M
What is Keros Therapeutics quarterly retained earnings year-on-year change?
Over the past year, KROS quarterly retained earnings has changed by -$181.57 M (-53.22%)